Zynerba Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ZYNE and buy or sell other stocks, ETFs, and their options commission-free!About ZYNE
Zynerba Pharmaceuticals, Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. It focuses on the research and development of rare and near-rare neuropsychiatric conditions.
CEOArmando Anido, MBA
CEOArmando Anido, MBA
Employees—
Employees—
HeadquartersDevon, Pennsylvania
HeadquartersDevon, Pennsylvania
Founded2007
Founded2007
Employees—
Employees—
ZYNE Key Statistics
Market cap70.12M
Market cap70.12M
Price-Earnings ratio-1.63
Price-Earnings ratio-1.63
Dividend yield—
Dividend yield—
Average volume585.87K
Average volume585.87K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.40
52 Week high$1.40
52 Week low$0.25
52 Week low$0.25
Stock Snapshot
The current Zynerba Pharmaceuticals(ZYNE) stock price is $1.30, with a market capitalization of 70.12M. The stock trades at a price-to-earnings (P/E) ratio of -1.63.
On 2026-01-02, Zynerba Pharmaceuticals(ZYNE) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Zynerba Pharmaceuticals(ZYNE) stock has reached 0, versus its average volume of 585.87K.
Over the past 52 weeks, Zynerba Pharmaceuticals(ZYNE) stock has traded between a high of $1.40 and a low of $0.25.
Over the past 52 weeks, Zynerba Pharmaceuticals(ZYNE) stock has traded between a high of $1.40 and a low of $0.25.
People also own
Based on the portfolios of people who own ZYNE. This list is generated using Robinhood data, and it’s not a recommendation.